NZ273815A - Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides - Google Patents

Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides

Info

Publication number
NZ273815A
NZ273815A NZ273815A NZ27381594A NZ273815A NZ 273815 A NZ273815 A NZ 273815A NZ 273815 A NZ273815 A NZ 273815A NZ 27381594 A NZ27381594 A NZ 27381594A NZ 273815 A NZ273815 A NZ 273815A
Authority
NZ
New Zealand
Prior art keywords
isolated
autoimmune diseases
peptide compositions
diseases containing
purified peptides
Prior art date
Application number
NZ273815A
Other languages
English (en)
Inventor
Malcolm L Gefter
Ze Ev Shaked
Malcolm Morville
Original Assignee
Immulogic Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immulogic Pharma Corp filed Critical Immulogic Pharma Corp
Priority to NZ273815A priority Critical patent/NZ273815A/xx
Publication of NZ273815A publication Critical patent/NZ273815A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ273815A 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides NZ273815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ273815A NZ273815A (en) 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ273815A NZ273815A (en) 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
PCT/US1994/010262 WO1996007428A1 (fr) 1994-09-02 1994-09-02 Compositions peptidiques pouvant reguler a la baisse une reponse immunitaire specifique a un antigene

Publications (1)

Publication Number Publication Date
NZ273815A true NZ273815A (en) 1999-05-28

Family

ID=22242963

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ273815A NZ273815A (en) 1994-09-02 1994-09-02 Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides

Country Status (6)

Country Link
EP (1) EP0783322A1 (fr)
JP (1) JPH10505356A (fr)
AU (1) AU7726094A (fr)
CZ (1) CZ63297A3 (fr)
NZ (1) NZ273815A (fr)
WO (1) WO1996007428A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE296444T1 (de) * 1996-03-21 2005-06-15 Circassia Ltd Kryptische peptide und verfahren zu ihrer identifizierung
DE10359352A1 (de) * 2003-12-16 2005-07-21 Merck Patent Gmbh DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Lol p 4
PT1868642E (pt) 2005-03-18 2013-07-10 Cytos Biotechnology Ag Proteínas de fusão de alergénios de gato e suas utilizações
GB0710529D0 (en) 2007-06-01 2007-07-11 Circassia Ltd Vaccine
GB0821806D0 (en) 2008-11-28 2009-01-07 Circassia Ltd Compositions with reduced dimer formation
PT2367561E (pt) 2008-11-30 2015-10-23 Immusant Inc Composições e métodos para o tratamento da doença celíaca
AU2014318889B2 (en) 2013-09-10 2020-02-20 Immusant, Inc. Dosage of a gluten peptide composition
EP3201354A1 (fr) 2014-09-29 2017-08-09 Immusant Inc. Utilisation de statut génétique hla pour évaluer ou sélectionner un traitement de la maladie c liaque

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0636180A1 (fr) * 1992-04-09 1995-02-01 Immulogic Pharmaceutical Corporation EPITOPES DE LYMPHOCYTES T DES PRINCIPAUX ALLERGENES D'$i(AMBROSIA ARTEMISIIFOLIA)
AU5668194A (en) * 1992-11-12 1994-06-08 Immulogic Pharmaceutical Corporation Allergenic proteins and peptides from japanese cedar pollen
WO1994021675A2 (fr) * 1993-03-12 1994-09-29 Immulogic Pharmaceutical Corporation Determinants antigeniques de lymphocites t de l'allergene contenu dans le pollen du ray-grass
AU674584B2 (en) * 1993-06-02 1997-01-02 Tvw Telethon Institute For Child Health Research Cryptic peptides for use in inducing immunologic tolerance
EP0714440A1 (fr) * 1993-08-13 1996-06-05 Immulogic Pharmaceutical Corporation Epitopes de lymphocyte t pour l'allergene du ray-grass

Also Published As

Publication number Publication date
WO1996007428A1 (fr) 1996-03-14
JPH10505356A (ja) 1998-05-26
AU7726094A (en) 1996-03-27
EP0783322A1 (fr) 1997-07-16
CZ63297A3 (en) 1997-08-13

Similar Documents

Publication Publication Date Title
EP0785276A4 (fr) Modification d'un peptide et d'une proteine
HK1003503A1 (en) Aerosol formulations of peptides and proteins
SG52542A1 (en) Analogs of peptide yy and uses thereof
SI0881906T1 (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
IL114407A0 (en) Novel peptides and pharmaceutical compositions comprising them
HRP950612B1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
AU1159897A (en) Analogs of peptide yy and uses thereof
AU6428890A (en) Therapeutic peptides and proteins
NZ273815A (en) Peptide compositions for treating protein allergies or autoimmune diseases containing at least two isolated and purified peptides
GB9614033D0 (en) Modified protein G and fragments thereof
IL116973A0 (en) Extraction of recombinant proteins
HUP9900089A3 (en) Peptide derivatives of dolastatin 15
EP0821694A4 (fr) Peptides de conotoxine
HUP9801680A3 (en) Peptides and remedy for autoimmune diseases comprising the same
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
DE69427363T2 (de) Plättchenaggregationsinhibierende peptide
HU9401824D0 (en) Soybean protein or hydrolylates in pharmaceutical compositions to protect bioaltive peptides from enlymatic nactivation
GB2336844B (en) Anti-hiv peptides and proteins
HK1024006A1 (en) Peptide as diagnostic and therapeutic agent for autoimmune diseases
DE69420044D1 (de) Blutregulierende peptide
IL112094A0 (en) Novel peptides and pharmaceutical compositions comprising them
IL109911A0 (en) Enhanced expression of peptide molecules
BR9507063A (pt) Peptídeo derivado de substituição de peptídeo e composição farmacêuticas
IL116976A0 (en) Synthetic peptides and pharmaceutical compositions comprising them
AU3818095A (en) Separation of amino acids and peptides from protein hydrolysates

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
ASS Change of ownership

Owner name: MERCK PATENT GMBH, DE

Free format text: OLD OWNER(S): HESKA CORPORATION

Owner name: MERCK PATENT GMBH, DE

Free format text: OLD OWNER(S): MERCK PATENT GMBH

EXPY Patent expired